The Liver Meeting 2019-Predictors of Disease Progression and Complications of Primary Sclerosing Cholangitis

Predictors of Disease Progression and Complications of Primary Sclerosing Cholangitis

Video Transcription

Video Summary

In this video transcript, a case study of a 33-year-old man with primary sclerosing cholangitis (PSC) is discussed. The focus is on biomarkers, specifically IgG4 levels, ALKFOS levels, and CA99 levels, and their implications for disease diagnosis and prognosis. The transcript highlights the challenges of interpreting these biomarkers in the context of PSC and other potential conditions. It also emphasizes the importance of regular patient monitoring, consideration of advanced imaging techniques, and the potential role of omics technologies for improving patient management. Overall, the discussion revolves around the complexities of diagnosing and managing PSC, the risks of complications such as cholangiocarcinoma, and the evolving landscape of biomarker utilization in clinical practice. The key takeaway is the need for a multifaceted approach to patient care and the importance of integrating various diagnostic modalities for optimal outcomes.

Asset Caption

Presenter: Tom H. Karlsen

Keywords

primary sclerosing cholangitis

biomarkers

IgG4 levels

ALKFOS levels

CA99 levels